Relationship between paclitaxel activity and pathobiology of human solid tumors

Clinical Cancer Research

Volumn 4, Issue 12, 1998, Pages 2949-2955

  Gan, Yuebo ^a   Wientjes, M Guillaume ^a   Au, Jessie L S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PROTEIN BCL 2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER GRADING; DISEASE SEVERITY; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TARGET CELL DESTRUCTION; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; P-GLYCOPROTEIN; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032425823     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rowinski, E. K., Wright, M., Monsarrat, B., Lesser, G. J., and Donehower, R. C. Taxol. Pharmacology, metabolism and clinical implications. Cancer Surv., 17: 283-301, 1993.
2. Schiff, P. B., and Horwitz, S. B. Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate or microtubule-associated proteins. Biochemistry, 20: 3247-3252, 1981.
3. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
4. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
5. Gan, Y., Wientjes, M. G., Schuller, D. E., and Au, J. L-S. Pharmacodynamics of Taxol in human head and neck tumors. Cancer Res., 56: 2086-2093, 1996.
6. Chen, C. T., Au, J. L-S., Gan, Y., and Wientjes, M. G. Differential time dependency of antiproliferative and apoptotic effects of Taxol in human prostate tumors. Urol. Oncol., 3: 11-17, 1997.
7. Au, J. L-S., Kalns, J., Gan, Y., and Wientjes, M. G. Pharmacologic effects of taxol in human bladder tumors. Cancer Chemother. Pharmacol., 41: 69-74, 1997.
8. Millenbaugh, N. J., Gan, Y., and Au, J. L-S. Cytostatic and apoptotic effects of paclitaxel in human ovarian tumors. Pharm. Res., 13: 123-138, 1998.
9. Gan, Y., Lu, J., and Au, J. L-S. Cytostatic and apoptotic effects of paclitaxel in human breast tumors. Cancer Chemother. Pharmacol., In press, 1998.
10. Horwitz, S. B. Mechanism of action of Taxol. Trends Pharmacol. Sci., 13: 134-136, 1992.
11. Horwitz, S. B., Cohen, D., Rao, S., Ringel, I., Shen, H. J., and Yang, C. P. Taxol: mechanism of action and resistance. J. Natl. Cancer Inst. Monogr., 15: 55-61, 1993.
12. Tang, C., Willingham, M. C., Reed, J. C., Miyashita, T., Ray, S., Ponnathpur, V., Huang, Y., Mahoney, M. E., Bullock, G., and Bhalla, K. High levels of p26bcl-2 retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia (Baltimore), 8: 1960-1969, 1994.
13. Robbins, K. T., Connors, K. M., Storniolo, A. M., Hanchett, C., and Hoffman, R. M. Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Arch. Otolaryngol. Head Neck Surg., 120: 288-292, 1994.
14. Furukawa, T., Kubota, T., and Hoffman, R. M. The clinical applications of the histoculture drug response assay. Clin. Cancer Res., 1: 305-311, 1995.
15. Kubota, T., Sasano, N., Abe, O., Nakao, I., Kawamura, E., Saito, T., Endo, M., Kimura, K., Demura, H., Sasano, H., Nagura, H., Ogawa, N., Hoffman, R., and the Chemosensitivity Study Group for the Histoculture Drug-Response Assay. Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin. Cancer Res., 1: 1537-1543, 1995.
16. Au, J. L-S., Panchal, N., Li, D., and Gan, Y. Apoptosis. A new pharmacodynamic endpoint. Pharm. Res., 14: 1659-1671, 1997.
17. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., and Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med., 1: 506-526, 1995.
18. 2/M arrest and apoptosis. Nat. Med., 2: 72-79, 1996.
19. Wu, G. S., and El-Deiry, W. S. p53 and chemosensitivity. Nat. Med., 2: 255-256, 1996.
20. Debernardis, D., Graniela Sire, E., Feudis, P. D., Vikhanskaya, F., Valenti, M., Russo, R., Parodi, S., D'Incalci, M., and Broggini, M. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res., 57: 870-874, 1997.